BBNX News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

BB

Mkt Cap

$884.3M

Volume

444.62K

Next Earnings

October 27th

Loading chart

BB

BBNXBeta Bionics, Inc. Common Stock

BBNX

Pay with—

Available Balance0.00

BB

Mkt Cap

$882.0M

Volume

444.62K

Next Earnings

October 27th

Chart Financials Earnings News About Insider Filings

ROSEN, A LONGSTANDING FIRM, Encourages AppLovin Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – APPRosen Law Firm has filed securities class action lawsuits against AppLovin Corporation, Lincoln Educational Services Corporation, and Beta Bionics, Inc. The AppLovin lawsuit alleges the company made false statements regarding AI video creative features and overstated the benefits of its AI models. Investors who purchased securities during specified class periods are encouraged to seek counsel before upcoming lead plaintiff deadlines.GlobeNewswire Inc. · Oct 15, 2026

BBNX DEADLINE NOTICE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Beta Bionics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - BBNXRosen Law Firm is notifying Beta Bionics, Inc. investors of a November 3, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Beta Bionics made false statements about its iLet Bionic Pancreas insulin pump, which the FDA found to be malfunctioning and causing dangerously high insulin dosing. The company allegedly failed to implement meaningful corrective actions despite thousands of complaints and hundreds of life-threatening events.GlobeNewswire Inc. · Oct 15, 2026

Beta Bionics, Inc. Class Action Reminder - Robbins LLP Encourages BBNX Investors to Contact the Firm for Information About Their RightsRobbins LLP reminds investors of a class action lawsuit against Beta Bionics (BBNX) for allegedly misleading investors about the safety and efficacy of its iLet insulin pump. The company failed to disclose serious FDA concerns about device malfunctions causing dangerously high insulin doses and hypoglycemic events. Stock fell from $31.99 to $12.89 per share between January and February 2026 following FDA warning letter disclosures.GlobeNewswire Inc. · Oct 14, 2026

Bronstein, Gewirtz & Grossman LLC Urges Beta Bionics, Inc. Investors to Act: Class Action Filed Alleging Investor HarmA class action lawsuit has been filed against Beta Bionics, Inc. for alleged securities fraud. The complaint alleges that the company made materially false and misleading statements regarding FDA observations about its iLet Bionic Pancreas insulin pump, including undisclosed quality management deficiencies and unreported serious customer injuries. Investors who purchased Beta Bionics securities between July 30, 2025 and February 24, 2026 are encouraged to join the case, with a lead plaintiff deadline of November 3, 2026.GlobeNewswire Inc. · Oct 14, 2026

Beta Bionics, Inc. Notice of November 3, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application DeadlineA class action securities lawsuit has been filed against Beta Bionics, Inc. for allegedly making false statements about its iLet Bionic Pancreas insulin pump. The lawsuit claims the device's automated dosing algorithm malfunctioned, delivering dangerously high insulin levels causing hypoglycemic events, and that the company failed to disclose thousands of complaints to the FDA. Investors who purchased stock between July 30, 2025 and February 24, 2026 can apply to be lead plaintiff by November 3, 2026.GlobeNewswire Inc. · Oct 14, 2026

AEVEX Corp. Notice of October 20, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application DeadlineKahn Swick & Foti, LLC announces class action securities lawsuits against AEVEX Corp., Beta Bionics, Inc., and York Space Systems, Inc. The primary case alleges that AEVEX and its executives concealed a pre-arranged plan to prematurely override a 180-day lock-up commitment, allowing Madison to sell shares and generate over $200 million through a secondary offering. Investors who purchased shares during the class periods have until the specified deadlines to request lead plaintiff status.GlobeNewswire Inc. · Oct 14, 2026

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Beta Bionics, Inc. of Class Action Lawsuit and Upcoming Deadlines – BBNXPomerantz Law Firm has filed a class action lawsuit against Beta Bionics, Inc. (NASDAQ: BBNX) alleging securities fraud related to its iLet insulin pump device. The company allegedly misrepresented FDA concerns and failed to properly report thousands of patient complaints. The lawsuit follows significant stock price declines after the FDA issued a warning letter in February 2026, revealing more serious safety and reporting issues than Beta Bionics had previously disclosed. Investors have until November 3, 2026, to join the class action.GlobeNewswire Inc. · Oct 13, 2026

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Beta Bionics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BBNXA securities class action lawsuit has been filed against Beta Bionics, Inc. (BBNX) for allegedly making false and misleading statements about its iLet Bionic Pancreas insulin pump. The FDA raised serious concerns about the device malfunctioning and delivering dangerously high insulin doses, causing hypoglycemic events. The company allegedly failed to implement meaningful corrective actions. Investors who purchased BBNX stock between July 30, 2025 and February 24, 2026 may be eligible for compensation. The lead plaintiff deadline is November 3, 2026.GlobeNewswire Inc. · Oct 12, 2026

ROSEN, A LEADING LAW FIRM, Encourages Beta Bionics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BBNXRosen Law Firm is urging investors who purchased Beta Bionics common stock between July 30, 2025 and February 24, 2026 to join a securities class action lawsuit. The lawsuit alleges that Beta Bionics made materially false and misleading statements about its iLet Bionic Pancreas insulin pump, which the FDA found was malfunctioning and dosing patients with dangerously high insulin levels. The firm claims thousands of complaints were filed with the FDA, contradicting defendants' assertions that issues were benign. The lead plaintiff deadline is November 3, 2026.GlobeNewswire Inc. · Oct 10, 2026

BBNX INVESTOR DEADLINE: Beta Bionics Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit - HBSSBeta Bionics (NASDAQ: BBNX) faces a securities class action lawsuit for allegedly misleading investors about its iLet automated insulin delivery system. The company concealed thousands of safety complaints, including life-threatening hypoglycemic events, and failed to report them to the FDA as required. An FDA warning letter in February 2026 revealed the violations, causing significant shareholder losses during the class period of July 30, 2025 to February 24, 2026.GlobeNewswire Inc. · Oct 9, 2026

to start trading

BB

BBNXBeta Bionics, Inc. Common Stock

BBNX

Pay with—

Available Balance0.00

Your PositionYou don't own any BBNX yet.

Related Tickers

Earnings